🔎 Trials Near Me

Home › Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis clinical trials recruiting in the U.S.

18 studies for Relapsing-Remitting Multiple Sclerosis are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Sep 16, 2026 · NCT04047628

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Recruiting
Ages 22 to 60 · All sexes · Updated Sep 2, 2026 · NCT06796504

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.

RecruitingObservational study
Ages 40 to 70 · All sexes · Updated Aug 11, 2026 · NCT07758270

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Recruiting
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT06864936

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

RecruitingPhase 1/2
Ages 18 to 55 · All sexes · Updated Jul 2, 2026 · NCT05359653

Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis

Recruiting
Ages 45 to 89 · All sexes · Updated Jun 17, 2026 · NCT06919900

Intermittent Hypoxia in Persons With Multiple Sclerosis

Recruiting
Ages 18 to 75 · All sexes · Updated Mar 20, 2026 · NCT06276634

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Mar 17, 2026 · NCT07225361

Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

Recruiting
Ages 18 to 100 · All sexes · Updated Mar 6, 2026 · NCT07376772

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Recruiting
Ages 18 to 75 · All sexes · Updated Feb 23, 2026 · NCT06390930

Effects of Ublituximab on Motor Functions in Multiple Sclerosis

RecruitingEarly phase 1
Ages 18 to 55 · All sexes · Updated Feb 9, 2026 · NCT06629428

Home Based Functional Balance Intervention for Multiple Sclerosis

Recruiting
Ages 40 to 90 · All sexes · Updated Jan 21, 2026 · NCT07355387

"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 31, 2025 · NCT07222618

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2025 · NCT05964829

MS-ResearchBiomarkerS

RecruitingObservational studyHealthy volunteers welcomeMentions payment for participants
Ages 18 and older · All sexes · Updated Feb 6, 2024 · NCT05204459

Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis

RecruitingObservational study
Ages 18 to 60 · All sexes · Updated Jun 6, 2022 · NCT04458688

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.